INSIGHTS ON CLINICAL TRIAL TECHNOLOGIES

• Paper COAs In 2026? It's Not "Cheaper," It's Riskier

  Paper-based assessments add operational and regulatory risk — from poor data quality to delayed insights — quietly threatening timelines, compliance, and trial confidence.

• Advancing Digital Measures From Scientific Rigor To Real-World Impact

  Discover how digital health technologies are moving from experimental tools to validated clinical endpoints through regulatory alignment, AI integration, and cross-industry collaboration.

• Empowering Mid-Size Pharma Companies With Integrated Drug Development, Regulatory Strategy, And AI Innovation

  A consultative, tech-enabled CRO can help mid-size pharma achieve targets by supplementing skillsets, expanding global reach, and designing an effective clinical, regulatory, and operational strategy.

• Monitoring Activity And Gait In Children Using DHTs

  Drug developers, researchers, patients, and regulators are recognizing the benefits of sensor-based digital health technologies for clinical research.

• Impacting Sustainability Through Vendor Collaboration, Procurement

  9/12/2024

  Guido D’Agostino, Head of Global Procurement at Chiesi, and Stefan Dürr, Senior Director of Product Management and Client Delivery at IQVIA IRT, delve into their achievements in sustainability.

• Has Your Clinical Trial Outgrown Its RTSM Software? Here's What to Watch For

  3/25/2026

  This clip explores how rigid RTSM systems push teams into risky manual workarounds and highlights why flexible, adaptable technology is essential when studies evolve and operational demands shift.

• Accelerating Enrollment And Upholding Quality In Complex Oncology Trials

  5/5/2026

  Real-world oncology trials reveal how fast physician engagement, hands-on biomarker management, and adaptive enrollment shorten timelines, reach first-patient milestones, and preserve data quality.

• Automated Evidence Generation For Regulatory-Grade RWD

  10/20/2025

  Global regulatory agencies increasingly adopt Real-World Evidence, demanding higher data quality and automated AI-driven platforms to meet evolving standards and improve drug development pathways.

• Improving The eCOA Experience

  1/25/2026

  Discover how template-driven builds and reuse can slash eCOA timelines by 50% while solving the licensing and translation hurdles that delay First Patient In.